Non-invasive screening & genomics in NAFLD with the Fatty liver Foundation

On 3rd March 2021 Sano Genetics hosted a webinar with the Fatty Liver Foundation talking about their mission to improve early detection in NAFLD (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis) using genetics, non-invasive liver testing, and other new technologies.


Our panel of experts


Wayne Eskridge-1

Wayne Eskridge

CEO & Founder
Fatty Liver Foundation

Dr. Neeraj Mistry-1

Dr. Neeraj Mistry

Chief Medical Officer
Fatty Liver Foundation